Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: Africa Malaria Day --- April 25, 2006
Approximately 90% of the estimated 1 million deaths caused by malaria each year occur in Africa, where every 30 seconds
a child dies from malaria (1). To confront this public health problem, on April 25, 2000, government leaders from
44 African countries met in Abuja, Nigeria, and signed the Abuja Declaration, committing their countries to decreasing
malaria deaths in Africa by 50% by 2010 (2). This event has been commemorated every year since on Africa Malaria
Day.*
This year's theme, Universal Access to Effective Malaria Treatment Is a Human Right, and the associated slogan, Get
your ACT Together!, underscore the importance of ensuring access to artemisinin-based combination treatment (ACT).
Because chloroquine is no longer effective in Africa and resistance is increasing to other first-line antimalarials, the World
Health Organization has recommended a change to ACTs, and many African countries now recommend first-line use of ACT, a
more expensive, but more effective drug regimen
(3).
Africa Malaria Day also is an occasion to recognize renewed global commitment to the fight against malaria. On
Africa Malaria Day in 2005, the World Bank pledged $500 million to $1 billion over the next 5 years to its Global Strategy
and Booster Program for Malaria Control to strengthen program design and implementation, increase intervention coverage,
and improve outcomes. Antimalaria projects have been
approved in the Democratic Republic of the Congo, Eritrea, Niger,
and Zambia, and preparations are under way in nine additional countries.
In May 2005, the Program for Appropriate Technology in Health (PATH), an international nonprofit organization,
partnered with Zambia to promote rapid scale-up of malaria interventions in sub-Saharan Africa. The Malaria Control and
Evaluation Partnership in Africa, consisting of PATH, the Government of Zambia, and other local and global partners, is working to
increase malaria prevention and control and assess
the impact on morbidity and mortality of major interventions,
including case management, personal protection with insecticide-treated nets (ITNs) and indoor residual spraying (IRS), and prevention
of malaria during pregnancy. Before and during the recent transmission season, the Zambian government distributed
approximately 500,000 ITNs and retreatment kits, extended IRS to eligible households in 15 districts, and extended ACT coverage to all
district health facilities.
On June 30, 2005, the President's Malaria Initiative
(PMI) pledged $1.2 billion over the next 5 years to support
malaria prevention and treatment in sub-Saharan Africa. PMI's goal is to reduce malaria deaths by 50% in each of the target
countries after 3 years of full implementation. In December 2005 and January 2006, the United States, in partnership with ministries
of health, nongovernmental organizations, academia, and private industries, launched PMI in the first three target
countries (Angola, Tanzania, and Uganda) with distribution of more than 300,000 ITNs and IRS of 100,000 homes. PMI plans
to ultimately reach 175 million people in up to 15 or more African countries most affected by malaria. PMI activities
are integrated with the Global Fund to Fight AIDS,
Tuberculosis, and Malaria, which has more than $1 billion for
malaria interventions.
References
Bryce J, Boschi-Pinto C, Shibuya K, Black RE, WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death
in children. Lancet 2005;365:1147--52.
Roll Back Malaria Partnership, World Health Organization. The Abuja Declaration and the plan of action. Geneva, Switzerland: World
Health Organization; 2000. Available at
http://www.rbm.who.int/docs/abuja_declaration.pdf.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
